| Understand how to show value and gain stakeholder trust |
|
|
While demonstrating the value of a product is important for any organization, the pressure is more acute for small and emerging biotech companies. It’s critical to convey to investors that your drug candidate has the potential to meet the unmet needs of patients today and tomorrow.
|
|
|
We’ve identified three key components to creating a compelling value story. In this white paper we’ll explore:
|
- Articulating your product vision, along with a Target Product Profile (TPP), an important tool in shaping the route through clinical development
- Choosing the right development path – making decisions based on time, cost and risk trade-offs
- Demonstrating your approach has merit by creating your expected net present value (eNPV) metric.
|
|
